Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07235358 · ClinicalTrials.gov registry record · NA

Cardiometabolic Effects of Pecan Snacking in Prediabetes

A NA study, sponsored by Penn State University.

Recruiting
Registry status
NA
Development phase
147
Enrollment target

NCT07235358: Recruiting NA study, sponsored by Penn State University.

NCT07235358 is a NA study that is actively recruiting participants, run by Penn State University. The registered enrollment target is 147 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07235358, a NA study, is actively recruiting participants, sponsored by Penn State University.

RECRUITING
Registry status
NA
Development phase
147 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the effects of replacing snacks higher in saturated fats and added sugars with pecans on blood sugar control, heart health and diet quality in individuals with prediabetes. Participants will be randomized into one of two groups. Group 1 will consume 1.5 oz of pecans per day in place of normally consumed snacks higher in saturated fat and added sugars for 16 weeks. Group 2 will be asked to continue consuming their current diet for 16 weeks. Measures will be taken to evaluate blood sugar, heart health and dietary intake at the beginning and 16 weeks later.

Primary Outcome

HbA1c will be assessed at baseline and 16-weeks and expressed as percentage . The change in HbA1c will be calculated by subtracting the baseline value from the 16 week value and expressed as percentage point change.

Interventions

  • OTHER Usual diet
  • BEHAVIORAL Pecan snacking

Trial Details

FieldValue
Enrollment Target 147 participants
Start Date 2026-05-22
Est. Completion 2027-09-30
Phase NA
Penn State University

219 total trials

What NCT07235358 shows while recruiting

NCT07235358 is an interventional study that assigns participants to a tested intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which Usual diet is the first listed.

NCT07235358 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07235358 about?

NCT07235358 is a clinical study titled "Cardiometabolic Effects of Pecan Snacking in Prediabetes". The purpose of this study is to investigate the effects of replacing snacks higher in saturated fats and added sugars with pecans on blood sugar control, heart health and diet quality in individuals with prediabetes. Participants will be randomized into one of two groups. Group 1 will consume 1.5 oz...

What is the current status of trial NCT07235358?

This trial is currently recruiting. It is a NA study. The enrollment target is 147 participants. The study started on 2026-05-22. Estimated completion is 2027-09-30.

What interventions are being tested in trial NCT07235358?

The interventions under investigation include: Usual diet (OTHER), Pecan snacking (BEHAVIORAL).

Who is sponsoring clinical trial NCT07235358?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07235358's enrollment target sits among peer trials

147 703rd of 2000 higher than 1,297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04396613 · 147 participants · NA

    Wound Closure Techniques in Primary Spine Surgery

  • NCT04851119 · 147 participants · Phase 1

    Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • NCT05523947 · 147 participants · Phase 1

    Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

  • NCT06121843 · 147 participants · Phase 1

    A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07235358, the US trial registry maintained by the National Library of Medicine. NCT07235358 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.